Cadonilimab (AK104) 是一种靶向
PD1/
CTLA4的 IgG1 支架 Fc 工程人源化抗体。Cadonilimab 可用于转移性宫颈癌的研究。
| 生物活性 |
Cadonilimab (AK104) is a targetingPD1/CTLA4IgG1scaffold Fc-engineered humanized antibody. Cadonilimab can be used for researching metastatic cervicalcancer[1][2].
|
| IC50& Target |
|
| Clinical Trial |
|
| 性状 |
|
| CAS 号 |
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
m.cnreagent.com
